A Pharmacist's Guide to Recent Treatment Guidelines On Type 2 Diabetes
Activity Date: July 2007  — Activity Info: Volume4, (6)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

To provide ambulatory pharmacists with up-to-date information regarding their role in the management and treatment of patients with type 2 diabetes mellitus.

This activity is designed for ambulatory pharmacists. No prerequisites required.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
  • Recognize the epidemiology, pathophysiology, and economic impact of type 2 diabetes mellitus (DM).
  • Discuss the recent American Diabetes Association/European Association for the Study of Diabetes Guidelines on management of hyperglycemia in type 2 DM, including safety and efficacy of current pharmacologic treatments.
  • Describe the role of new and emerging medications as it relates to efficacy, safety, and place in current therapy.
  • Identify the role of the pharmacist in reinforcing current treatment guidelines through patient counseling.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.

This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Program #064-000-07-208-H01-P.

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity: 2 hours.

Release date: July 15, 2007. Expiration date: July 15, 2009.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

 A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This program is supported by an educational grant from King Pharmaceuticals and Depomed, Inc.
Home | Contact Us | View Account | Need Help?